Duration of Time CD4/CD8 Ratio is Below 0.5 is Associated with Progression to Anal Cancer in Patients with HIV and High-Grade Dysplasia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
https://link.springer.com/content/pdf/10.1245/s10434-023-13213-z.pdf
Reference26 articles.
1. Lee JY, Lensing SY, Berry-Lawhorn JM, Jay N, Darragh TM, Goldstone SE, et al. Design of the ANal Cancer/HSIL outcomes research study (ANCHOR study): a randomized study to prevent anal cancer among persons living with HIV. Contemp Clin Trials. 2022;113:106679. https://doi.org/10.1016/j.cct.2022.106679.
2. Gaisa M, Sigel K, Hand J, Goldstone S. High rates of anal dysplasia in HIV-infected men who have sex with men, women, and heterosexual men. AIDS. 2014;28:215–22. https://doi.org/10.1097/QAD.0000000000000062.
3. Liu Y, Sigel K, Gaisa MM. Human papillomavirus genotypes predict progression of anal low-grade squamous intraepithelial lesions. J Infect Dis. 2018;2018(218):1746–52. https://doi.org/10.1093/infdis/jiy463.
4. Dandapani SV, Eaton M, Thomas CR Jr, Pagnini PG. HIV- positive anal cancer: an update for the clinician. J Gastrointest Oncol. 2010;1:34–44. https://doi.org/10.3978/j.issn.2078-6891.2010.005.
5. Brown G. Screening for Anal Dysplasia and Cancer in Patients With HIV. New York State Clinical Guidelines Program, Department of Health AIDS Institute; 2020.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Monitoring immune recovery on HIV therapy: critical, helpful, or waste of money in the current era?;AIDS;2024-02-01
2. Severe anal intraepithelial neoplasia trends and subsequent invasive anal cancer in the United States;JNCI: Journal of the National Cancer Institute;2023-08-26
3. Idiopathic CD4 Lymphocytopenia at 30 Years;New England Journal of Medicine;2023-08-17
4. ASO Author Reflections: Using Objective Markers to Tailor Frequency of Anal Dysplasia Treatments in People Living with HIV;Annals of Surgical Oncology;2023-03-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3